Raphael Pharmaceutical Inc (RAPH)
0.26
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Raphael Pharmaceutical Enterprise Value: 4.766M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.766M |
| November 01, 2024 | 4.766M |
| October 31, 2024 | 4.766M |
| October 30, 2024 | 4.766M |
| October 29, 2024 | 4.766M |
| October 28, 2024 | 4.766M |
| October 25, 2024 | 4.766M |
| October 24, 2024 | 4.766M |
| October 23, 2024 | 4.766M |
| October 22, 2024 | 30.89M |
| October 21, 2024 | 30.89M |
| October 18, 2024 | 30.89M |
| October 17, 2024 | 30.89M |
| October 16, 2024 | 30.89M |
| October 15, 2024 | 30.89M |
| October 14, 2024 | 30.89M |
| October 11, 2024 | 30.89M |
| October 10, 2024 | 30.89M |
| October 09, 2024 | 30.89M |
| October 08, 2024 | 30.89M |
| October 07, 2024 | 30.89M |
| October 04, 2024 | 30.89M |
| October 03, 2024 | 30.89M |
| October 02, 2024 | 30.89M |
| October 01, 2024 | 30.89M |
| Date | Value |
|---|---|
| September 30, 2024 | 30.89M |
| September 27, 2024 | 30.89M |
| September 26, 2024 | 30.89M |
| September 25, 2024 | 30.89M |
| September 24, 2024 | 30.89M |
| September 23, 2024 | 30.89M |
| September 20, 2024 | 30.89M |
| September 19, 2024 | 30.89M |
| September 18, 2024 | 30.89M |
| September 17, 2024 | 30.89M |
| September 16, 2024 | 30.89M |
| September 13, 2024 | 30.89M |
| September 12, 2024 | 30.74M |
| September 11, 2024 | 30.74M |
| September 10, 2024 | 30.74M |
| September 09, 2024 | 30.74M |
| September 06, 2024 | 30.74M |
| September 05, 2024 | 30.74M |
| September 04, 2024 | 30.74M |
| September 03, 2024 | 30.74M |
| August 30, 2024 | 30.74M |
| August 29, 2024 | 30.74M |
| August 28, 2024 | 30.74M |
| August 27, 2024 | 30.74M |
| August 26, 2024 | 30.74M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.766M
Minimum
Oct 23 2024
38.77M
Maximum
Jan 19 2023
24.20M
Average
23.36M
Median
Jun 16 2023
Enterprise Value Benchmarks
| InspireMD Inc | 16.33M |
| Pluri Inc | 24.31M |
| IDenta Corp | 2.022M |
| BiomX Inc | 13.85M |
| IR-Med Inc | 34.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.248M |
| Total Expenses (Quarterly) | 0.249M |
| EPS Diluted (Quarterly) | -0.01 |
| Earnings Yield | -61.54% |